BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
Existing human data do not support obvious fertility advantages
LEARN MORE Advocacy We represent the interests and concerns of our community, making sure that the needs of downtown residents are taken into account in decision-making processes
Order went through smoothly, shipping was quick, and everything arrived clean and surprisingly well packed for how quickly it was sent
Produced via solid-phase peptide synthesis with subsequent copper complexation, GHK-Cu is associated with matrix metalloproteinase regulation and growth factor signalling pathways
BPC-157 Alone Daily sustained signaling